Insulet Corporation PODD
146.51 USD -9.61 (-6.16%)
At closeNov 9, 2026, 5:19 AM EST
148.15 +1.64 +1.12%
Pre-market · Nov 9, 5:19 AM ET
143.28 Day range 155.60
126.40 52-week range 354.88
- YTD
- -48.46%
- 1 year
- -54.19%
Benzinga news
benzinga.com Barclays Maintains Equal-Weight on Insulet, Raises Price Target to $165 Barclays analyst Christopher Pasquale maintains Insulet (NASDAQ:PODD) with a Equal-Weight and raises the price target from $150 to $165.
benzinga.com UBS Maintains Neutral on Insulet, Raises Price Target to $171 UBS analyst Patrick Wood maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $150 to $171.
benzinga.com JP Morgan Maintains Neutral on Insulet, Raises Price Target to $170 JP Morgan analyst Robbie Marcus maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $152 to $170.- benzinga.com Citigroup Maintains Neutral on Insulet, Raises Price Target to $170 Citigroup analyst Joanne Wuensch maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $150 to $170.
- benzinga.com Leerink Partners Maintains Market Perform on Insulet, Raises Price Target to $167 Leerink Partners analyst Mike Kratky maintains Insulet (NASDAQ:PODD) with a Market Perform and raises the price target from $143 to $167.
- benzinga.com RBC Capital Maintains Outperform on Insulet, Raises Price Target to $180 RBC Capital analyst Kendall Au maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $160 to $180.
benzinga.com Bernstein Maintains Outperform on Insulet, Raises Price Target to $200 Bernstein analyst Lee Hambright maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $175 to $200.
benzinga.com Wells Fargo Maintains Equal-Weight on Insulet, Raises Price Target to $172 Wells Fargo analyst Lawrence Biegelsen maintains Insulet (NASDAQ:PODD) with a Equal-Weight and raises the price target from $144 to $172.
benzinga.com Insulet CEO Sees Slower Growth in 2027, Expects Rivals to Chip Away at Omnipod's Market Share Insulet stock jumps on strong Q3 results, beating estimates with $842M in revenue, raising its 2026 outlook, and launching a $1B buyback.
benzinga.com Insulet Q3 2026 Earnings Call Transcript Insulet (NASDAQ:PODD) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com Insulet FY2026 Adj EPS expected to be more than $6.46 vs $6.46 Est; Raises FY2026 Sales Guidance from $3.250B-$3.304B to $3.277B-$3.304B vs $3.289B Est Insulet (NASDAQ:PODD) FY2026 expected to be more than $6.46 vs $6.46 Est. raises FY2026 sales outlook from $3.250 billion-$3.304 billion to $3.277 billion-$3.304 billion vs $3.289 billion estimate.- benzinga.com Insulet Q3 Adj. EPS $1.99 Beats $1.59 Estimate, Sales $842.000M Beat $832.685M Estimate Insulet (NASDAQ:PODD) reported quarterly earnings of $1.99 per share which beat the analyst consensus estimate of $1.59 by 25.16 percent. This is a 60.48 percent increase over earnings of $1.24 per…
- benzinga.com Jefferies Maintains Buy on Insulet, Lowers Price Target to $190 Jefferies analyst Matthew Taylor maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $275 to $190.